Revenues, including adjustments
Cumberland Pharmaceuticals·Products & Services·3 segments
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Vaprisol | -$1.62K | -$1.58K | -$135.77K | -$600 | -$14.62K | $600 | $517 |
| RediTrex | — | -$1.16K | $36.95K | -$347 | $3.24K | $4.43K | -$489 |
| Omeclamox-Pak | — | -$941 | -$18 | -$5.39K | -$752 | -$3.13K | $1 |
| Total | -$1.62K | -$1.58K | -$135.77K | -$600 | -$14.62K | $600 | $517 |